Top Story

Nicox, Ora enter into licensing agreement for AC-120 for morning eyelid swelling

February 5, 2016

Nicox has entered into a licensing agreement that grants Ora exclusive worldwide rights for the development and commercialization of Nicox’s AC-120 for the treatment of morning eyelid swelling, according to a press release.

Under the terms of the agreement, Ora will be responsible for development activities and funding of the program through its investment arm.

FDA News

Oculus receives 510(k) clearance for Pentacam AXL

February 5, 2016
The Pentacam AXL has received 510(k) clearance from the FDA, Oculus announced in a press release.The device, which combines anterior segment tomography and optical…
FDA News

FDA acknowledges receipt of Shire’s resubmitted NDA for lifitegrast

February 5, 2016
The FDA has acknowledged receipt of a new drug application resubmitted by Shire for lifitegrast to treat signs and symptoms of dry eye disease, the company announced in…
Meeting News CoverageVideo

VIDEO: Neuro-ophthalmologist encourages colleagues to check pupil as sign of serious disease

February 5, 2016
WAIKOLOA, Hawaii — At Hawaiian Eye, Andrew G. Lee, MD, discusses neuro-ophthalmology as an "ophthalmic superpower," which enables ophthalmologists to home in on life-…
Meeting News CoverageVideo

VIDEO: Surgeon discusses advantages of standard operating protocol for managing dry eye disease

February 4, 2016
WAIKOLOA, Hawaii — At Hawaiian Eye, Elizabeth Yeu, MD, discusses how implementing a standard protocol for assessing new cases of dry eye disease has made patient…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »

Taming the Difficult Diabetic Eye: Examining New Options for Treatment

This activity is supported by an educational grant from Genentech, Inc.

Proliferative diabetic retinopathy has long been one of the most challenging ocular conditions, as damage can be…
More »

VIDEO: Surgeon prefers fourth-generation fluoroquinolones as prophylaxis for cataract surgery

February 3, 2016
More »